NasdaqCM - Nasdaq Real Time Price USD

enVVeno Medical Corporation (NVNO)

5.0000

0.0000

(0.00%)

At close: May 10 at 4:00 PM EDT

5.2300

+0.23

(+4.60%)

After hours: May 10 at 7:23 PM EDT

Key Events

Loading Chart for NVNO

9/21 12:03 PM

DELL

Previous Close 5.0000
Open 4.9700
Bid --
Ask --
Day's Range 4.9300 - 5.0981
52 Week Range 2.5100 - 6.9700
Volume 75,540
Avg. Volume 125,266
Market Cap (intraday) 66.585M
Beta (5Y Monthly) 1.10
PE Ratio (TTM) --
EPS (TTM) -1.9100
Earnings Date Aug 5, 2024 - Aug 9, 2024
Forward Dividend & Yield --
Ex-Dividend Date --
1y Target Est --

enVVeno Medical Corporation, a clinical-stage medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of venous Chronic Venous Insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg; and enVVe, a non-surgical, transcatheter based replacement venous valve for the treatment of CVI. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.

www.envveno.com

31

Full Time Employees

December 31

Fiscal Year Ends

Sector

Medical Devices

Industry

Trailing total returns as of 5/10/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

NVNO

2.72%

S&P 500

9.49%

1-Year Return

NVNO

21.65%

S&P 500

26.79%

3-Year Return

NVNO

10.23%

S&P 500

23.39%

5-Year Return

NVNO

90.73%

S&P 500

81.93%

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

enVVeno Medical Corporation

5.0000

0.00%

Mkt Cap 66.585M

Industry Medical Devices

Spectral AI, Inc.

1.7100

+1.79%

Mkt Cap 30.031M

Industry Medical Devices

Sintx Technologies, Inc.

0.0399

-8.70%

Mkt Cap 4.895M

Industry Medical Devices

Outset Medical, Inc.

3.0700

-6.12%

Mkt Cap 158.726M

Industry Medical Devices

Treace Medical Concepts, Inc.

4.3800

-1.13%

Mkt Cap 271.595M

Industry Medical Devices

Shockwave Medical, Inc.

330.55

+0.00%

Mkt Cap 12.41B

Industry Medical Devices

7.27

-0.55%

Mkt Cap 156.999M

Industry Medical Devices

NovoCure Limited

16.47

+2.11%

Mkt Cap 1.772B

Industry Medical Devices

Viemed Healthcare, Inc.

7.15

+0.21%

Mkt Cap 277.375M

Industry Medical Devices

Sensus Healthcare, Inc.

5.29

+38.85%

Mkt Cap 86.721M

Industry Medical Devices

Heart Test Laboratories, Inc.

0.0880

-2.11%

Mkt Cap 5.769M

Industry Medical Devices

Valuation Measures

As of 5/10/2024

Market Cap

66.58M
Enterprise Value

21.57M
Trailing P/E

--
Forward P/E

--
PEG Ratio (5yr expected)

--
Price/Sales (ttm)

--
Price/Book (mrq)

1.44
Enterprise Value/Revenue

--
Enterprise Value/EBITDA

--

Financial Highlights

Profitability and Income Statement

Profit Margin

0.00%
Return on Assets (ttm)

-34.94%
Return on Equity (ttm)

-55.38%
Revenue (ttm)

--
Net Income Avi to Common (ttm)

-23.52M
Diluted EPS (ttm)

-1.9100

Balance Sheet and Cash Flow

Total Cash (mrq)

46.41M
Total Debt/Equity (mrq)

3.04%
Levered Free Cash Flow (ttm)

-10.37M

NVNO does not have Company Insights

RVPH Reviva Pharmaceuticals Holdings, Inc.

1.8700

-12.62%

UNCY Unicycive Therapeutics, Inc.

1.1300

+4.63%

EYEN Eyenovia, Inc.

0.7713

-4.14%

OCUP Ocuphire Pharma, Inc.

1.7200

-12.24%

ACXP Acurx Pharmaceuticals, Inc.

2.0300

+0.50%

TPST Tempest Therapeutics, Inc.

3.2500

-6.34%

RNAZ TransCode Therapeutics, Inc.

1.4100

+6.02%

CGTX Cognition Therapeutics, Inc.

1.9400

+1.57%

AVTX Avalo Therapeutics, Inc.

10.85

-5.57%

LTRN Lantern Pharma Inc.

6.16

-9.54%

CYTH Cyclo Therapeutics, Inc.

1.4700

+1.38%

CNTB Connect Biopharma Holdings Limited

1.5000

+4.90%

SABS SAB Biotherapeutics, Inc.

4.0100

+2.30%

XLO Xilio Therapeutics, Inc.

1.1800

-6.35%

NRSN NeuroSense Therapeutics Ltd.

1.1800

+2.61%

NRXP NRx Pharmaceuticals, Inc.

3.0400

+3.75%